Xiu-Min Li

机构：Westchester Medical Center, Guangdong University of Technology, New York Medical College, Chinese PLA General Hospital, Linyi People's Hospital, Liaoning Cancer Hospital & Institute · ORCID：0000-0002-5296-2960

发表论文 214 篇 · 总被引 7300 次 · h-index 42

代表论文

• Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China (2024 · The Lancet · 被引 112)
• A clinical study of autologous chimeric antigen receptor macrophage targeting mesothelin shows safety in ovarian cancer therapy (2024 · Journal of Hematology & Oncology · 被引 25)
• Artificial Intelligence and the New Quality Productive Forces of Enterprises: Digital Intelligence Empowerment Paths and Spatial Spillover Effects (2025 · Systems · 被引 22)
• Fertility restorer gene CaRf and PepperSNP50K provide a promising breeding system for hybrid pepper (2024 · Horticulture Research · 被引 10)
• The Etiology of IgE-Mediated Food Allergy: Potential Therapeutics and Challenges (2025 · International Journal of Molecular Sciences · 被引 9)
• Randomized, Phase III Trial of Mixed Formulation of Fosrolapitant and Palonosetron (HR20013) in Preventing Cisplatin-Based Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: PROFIT (2024 · Journal of Clinical Oncology · 被引 9)